SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
冰激凌UP
Lv3
368 积分
2024-05-29 加入
最近求助
最近应助
互助留言
Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy
1个月前
已完结
Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial
1个月前
已完结
The Etiology of Different Forms of Urticaria in Childhood
1个月前
已完结
Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma
1个月前
已完结
Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response
1个月前
已完结
IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria
1个月前
已完结
Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab
1个月前
已完结
The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change
1个月前
已完结
Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis
1个月前
已完结
Association Between Serum Total IgE Levels and Clinical Response to Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis
1个月前
已完结
没有进行任何应助
感谢,点赞,速度真快
1个月前
感谢,点赞,速度真快
1个月前
感谢,点赞
1个月前
感谢,点赞,速度真快
1个月前
感谢
1个月前
感谢,点赞,帮大忙了
1个月前
感谢,点赞,速度真快
1个月前
感谢,点赞,速度真快
1个月前
感谢,点赞,速度真快
1个月前
感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论